Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Merck & Co. announced that Kenneth C. Frazier, Chairman and Chief Executive Officer, has agreed to remain in his position beyond December 2019, when he turns 65. The company’s Board of Directors rescinded its policy subjecting the company’s CEO...

Alexion Pharmaceuticals, a Boston-headquartered pharmaceutical company, has agreed to acquire Syntimmune, a Boston, Massachusetts-based clinical-stage biopharmaceutical company developing antibody therapeutics targeting the neonatal Fc receptor...

The US Food and Drug Administration (FDA) has taken action to support recovery from Hurricane Florence, particularly to prevent drug shortages from pharmaceutical companies manufacturing important drugs. The hurricane struck North Carolina, South...

Allergan has agreed to acquire Bonti, a Newport Beach, California-based clinical-stage biopharmaceutical company focused on developing and commercializing fast-acting neurotoxin programs for aesthetic and therapeutic applications. Following...

The US Senate has passed The Opioid Crisis Response Act of 2018, bipartisan legislation that included over 70 proposals from five Senate committees to address the challenge of opioid misuse in the US. The bill, passed in a vote of 99-1, will now...

GlaxoSmithKline (GSK) has invested $36 million to modernize its site in Mississauga, Ontario, Canada into a consumer healthcare and prescription supply site. The investment enabled facility modifications, new equipment purchases, and enhanced...

Sanofi has announced plans to change the organizational structure of two of its global business units (GBUs) to provide greater focus on its operations in mature markets and emerging markets. The company says it will create a new Primary Care GBU...